| Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients LA Videla, R Rodrigo, M Orellana, V Fernandez, G Tapia, L Quiñones, ... Clinical science 106 (3), 261-268, 2004 | 600 | 2004 |
| CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people L Quinones, D Lucas, J Godoy, D Cáceres, F Berthou, N Varela, K Lee, ... Cancer letters 174 (1), 35-44, 2001 | 175 | 2001 |
| Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people C Acevedo, JL Opazo, C Huidobro, J Cabezas, J Iturrieta, ... The Prostate 57 (2), 111-117, 2003 | 94 | 2003 |
| Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations L Quinones, F Berthou, N Varela, B Simon, L Gil, D Lucas Cancer letters 141 (1-2), 167-171, 1999 | 89 | 1999 |
| Delphinol® standardized maqui berry extract reduces postprandial blood glucose increase in individuals with impaired glucose regulation by novel mechanism of sodium glucose … J Hidalgo, C Flores, MA Hidalgo, M Perez, A Yañez, L Quiñones, ... Panminerva Med 56 (2 Suppl 3), 1-7, 2014 | 85 | 2014 |
| Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian … Á Roco, L Quiñones, JAG Agúndez, E García-Martín, V Squicciarini, ... Frontiers in genetics 3, 229, 2012 | 85 | 2012 |
| Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype‐environment interaction study LA Quiñones, CE Irarrázabal, CR Rojas, CE Orellana, C Acevedo, ... Asian Journal of andrology 8 (3), 349-355, 2006 | 69 | 2006 |
| Clinical applications of pharmacogenomics. L Quiñones, Á Roco, JP Cayún, P Escalante, C Miranda, N Varela, ... Revista médica de Chile 145 (4), 483-500, 2017 | 59* | 2017 |
| Farmacocinética de medicamentos de uso pediátrico, visión actual I Saavedra, L Quiñones, M Saavedra, J Sasso, J León, A Roco Revista chilena de pediatría 79 (3), 249-258, 2008 | 58 | 2008 |
| Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene–gene and gene–environment interactions DD Cáceres L, J Iturrieta G, C Acevedo C, C Huidobro A, N Varela F, ... European journal of epidemiology 20, 79-88, 2005 | 54 | 2005 |
| Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women NM Varela, LA Quiñones, M Orellana, J Poniachik, A Csendes, G Smok, ... Biological research 41 (1), 81-92, 2008 | 52 | 2008 |
| Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America Current Drug Metabolism 15 (2), 202-208, 2014 | 49* | 2014 |
| Epithelial-mesenchymal transition and microRNAs in colorectal cancer chemoresistance to FOLFOX PI Escalante, LA Quinones, HR Contreras Pharmaceutics 13 (1), 75, 2021 | 38 | 2021 |
| Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure L Quiñones, K Lee, M Escala, K García, L Godoy, A Castro, J Soto, ... Rev Med Chile 134 (4), 499-515, 2006 | 38* | 2006 |
| High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis A Arenas, C Serrano, L Quiñones, P Harris, M Sandoval, M Lavanderos, ... Scientific Reports 9 (1), 20070, 2019 | 36 | 2019 |
| State of art of cancer pharmacogenomics in Latin American populations A López-Cortés, S Guerrero, MA Redal, AT Alvarado, LA Quiñones International Journal of Molecular Sciences 18 (6), 639, 2017 | 36 | 2017 |
| Pharmacogenetics, tobacco, alcohol and its effect on the risk development cancer Á Roco, B Cerda, JP Cayun, A Lavanderos, JC Rubilar, R Cerro, ... Revista chilena de pediatría 89 (4), 432-440, 2018 | 34* | 2018 |
| Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses N Varela, LA Quinones, J Stojanova, J Garay, D Cáceres, S Cespedes, ... Pharmacological Research 101, 124-129, 2015 | 34 | 2015 |
| Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy? Á Roco, J Cayún, S Contreras, J Stojanova, L Quiñones Frontiers in Genetics 5, 108582, 2014 | 34 | 2014 |
| Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer A López-Cortés, C Paz-y-Miño, S Guerrero, G Jaramillo-Koupermann, ... The Pharmacogenomics Journal 20 (1), 136-158, 2020 | 32 | 2020 |
Nelson VarelaProfesor Asociado, Facultad de Medicina, Universidad de ChileVerified email at med.uchile.cl
